Hydrogen Research Study
← Back to Research Library
Human clinical evidenceHuman Clinical StudyOther or not reported

The impact of hydrogen inhalation therapy on blood reactive oxygen species levels: A randomized controlled study.

Mohamed Chair, Hashem AlAani, Sevda Lafci Fahrioglu, Cherif Ben Hamda, Umut Fahrioglu, Tamer Degheidy · Free radical biology & medicine · 2024

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Hydrogen Inhalation Research
Evidence type Human clinical evidence
Publication type Human Clinical Study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence oxidative-stress regulation.

What the Findings Mean

The test group demonstrated a significant reduction in blood ROS levels after the treatment.

What the Researchers Studied

The study used a randomized human clinical trial. The comparison condition was control condition or baseline measurements.

What Effects Did Molecular Hydrogen Have?

The test group demonstrated a significant reduction in blood ROS levels after the treatment. The authors concluded that these findings suggested the efficacy of HIT in reducing oxidative stress.

Why These Findings Matter

These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence oxidative-stress regulation and contribute to the growing body of molecular-hydrogen research.

How Strong Is This Evidence?

This is human clinical evidence from a randomized human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.

Technical Study Details

H2HUBB classifies this publication as human clinical study with human clinical evidence. The reported sample size was 37. The study used a randomized human clinical trial.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.